On the reactor-based products and the processing that follows, I hope we'd look to design we'd learned from the lessons of the past. As I said, I think the European experience and the reasons companies like Covidien and Lantheus can interchange is that their European facilities have more flexibility. But I'll let Mr. Littlejohn speak to that.
On March 30th, 2010. See this statement in context.